The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
The CEP certification for Metformin Hydrochloride aligns with the company's strategy to penetrate stringently regulated markets
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
The plant will have installed production capacity of 3,120 MT/month
The programme will take place on the 2nd Sunday of every month
The company is committed to revolutionizing API development by advancing synthesis and analytical processes that enhance quality and impact lives
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
Subscribe To Our Newsletter & Stay Updated
